Myths and mysteries about staging hepatic fibrosis by fibroscan

2015 Clinical Gastroenterology & Hepatology 13;4 (780-782)

The staging of hepatic fibrosis is a cornerstone of the prognosis and assessment of disease progression in patients with chronic liver diseases including nonalcoholic steatohepatitis (NASH). This is because a histologic assessment of fibrosis has been the only clinically applicable read-out of such progression over the past century. The past 10 years, however, have seen numerous changes that have challenged classic paradigms and are creating new norms for the evaluation of progression and regression of chronic liver diseases.

Pubmed : 25451885